Indeed, ACKR3 has been shown to be upregulated on various tumor cells as well as on tumor-associated vasculature, therefore potentially interfering with the CXCR3–CXCL11 interactions [103,110,111,112]. The gene discussed is CXCL11; the disease is neoplasm.